• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Perfil cl?nico-epidemiol?gico de las defunciones por influenza con antecedente de vacunaci?n oportuna, M?xico 2010-2018

tetano

Editor, Senior Moderator
Gac Med Mex. 2019;155(5):457-463. doi: 10.24875/GMM.19004708. [h=1]Perfil cl?nico-epidemiol?gico de las defunciones por influenza con antecedente de vacunaci?n oportuna, M?xico 2010-2018.[/h]
Kuri-Morales PA[SUP]1[/SUP], Castillo-Flores GDD[SUP]2[/SUP], Casta?eda-Prado A[SUP]1[/SUP], Pacheco-Montes SR[SUP]3[/SUP].
[h=3]Author information[/h] 1 Universidad Nacional Aut?noma de M?xico, Facultad de Medicina, Ciudad de M?xico. M?xico. 2 Servicios de Salud de Veracruz, Subdirecci?n de Prevenci?n y Control de Enfermedades, Veracruz. M?xico. 3 Secretar?a de Salud, Direcci?n General de Epidemiolog?a, Ciudad de M?xico. M?xico.

[h=3]Abstract[/h] in English, Spanish
[h=4]Introduction:[/h] Influenza epidemics are of higher risk at the extremes of life and in people with comorbidities. Effective -vaccination prevents the occurrence of serious cases and decreases mortality.
[h=4]Objective:[/h] To describe deaths from influenza with a history of timely vaccination, from the 2010 to the 2018 season in Mexico.
[h=4]Method:[/h] Cross-sectional, descriptive study where the Influenza Epidemiological Surveillance System database was used.
[h=4]Results:[/h] From 2010 to 2018, 65 vaccinated individuals died from influenza, from which 55% of cases (n = 36) were due to type A (H1N1), 51% (n = 33) were females, median age was 57 years, 21 % (n = 14) did not meet the operational definition of influenza-like illness or severe acute respiratory infection, 83% (n = 54) had at least one comorbidity, with the most common being diabetes mellitus and hypertension (32% each); 55% (n = 36) of deaths received antiviral treatment and only 8% (n = 5) had no comorbidities and received treatment with oseltamivir.
[h=4]Conclusions:[/h] Deaths from influenza with timely vaccination represent a very low percentage of the totality. Vaccination against influenza has been a specific prevention strategy that decreases disease burden.
Copyright: ? 2019 Permanyer.


[h=4]KEYWORDS:[/h] Causa de defunci?n; Cause of death; Human influenza; Influenza humana; Vaccinationa; Vacunaci?n

PMID: 31695227 DOI: 10.24875/GMM.19004708
 
Back
Top Bottom